High-risk factors (HIV/AIDs, transplantation, silicosis, TNF-α blockers, close contacts, kidney dialysis) contribute to a significantly increased TB reactivation rate, and for countries with a low TB prevalence, patients with high-risk factors should undergo screening and treatment for LTBI. This evidence concerns the gene TNF and tuberculosis.